News | January 20, 2023
Blue Jet Healthcare gets SEBI nod for IPO
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
Connectivity and harmonisation were both key driving factors behind our decision to choose the CARA Life Sciences Platform to consolidate our processes
This donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba
AI-based medical imaging equipment firm Lunit has signed a contract to supply AI-based breast cancer screening solution “Lunit Insight MMG”
Through the new agreements, Cristal Therapeutics and McSAF will gain access to Lonza’s integrated bioconjugates offering and will be able to leverage Lonza’s expertise in developing and manufacturing bioconjugates
Dr. Reddy’s will manufacture the Active Pharmaceutical Ingredient and finished drug at its facilities approved by USFDA
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
Collaboration to generate and develop therapeutics for oncology and non-oncology conditions
The new project further expands the partner's long-term collaboration on new technologies for R&D
Subscribe To Our Newsletter & Stay Updated
